Article info
PDFPaper
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients
- Dr Emmanuelle Le Page, Service de Neurologie, Hôpital Pontchaillou, rue Henri Le Guilloux, 35 033 Rennes Cedex, France; emmanuelle.lepage{at}chu-rennes.fr
Citation
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients
Publication history
- Received May 15, 2007
- Revised August 13, 2007
- Accepted August 16, 2007
- First published September 10, 2007.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- Previous version (13 April 2016).
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group